Velindre Pharmaceuticals is categorized under Research and Development Laboratories in Thousand Oaks, CA and active since 2012.
Velindre Pharmaceuticals was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Terence R Jones at the company’s single location by writing to 1574 Campbell Avenue, Thousand Oaks, California CA 91360 or by phoning (858) 382-6247. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Velindre Pharmaceuticals |
| Contact Person: | Terence R Jones |
| Address: | 1574 Campbell Avenue, Thousand Oaks, California 91360 |
| Phone Number: | (858) 382-6247 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Velindre Pharmaceuticals was started in 2012 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Terence R Jones for inquiries that concern Velindre Pharmaceuticals by calling the company number (858) 382-6247, as your correspondence is most welcome. Additionally, the physical location of the single location of Velindre Pharmaceuticals can be found at the coordinates 34.200337,-118.889378 as well as the street address 1574 Campbell Avenue in Thousand Oaks, California 91360.
For its online presence, you may visit Velindre Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.